COMMUNIQUÉS West-GlobeNewswire

Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly

26/09/2024 - 22:05

SAN DIEGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for paltusotine [...]

Windtree Therapeutics Announces Virtual Investor Day Presentation on October 1 at 3pm ET

26/09/2024 - 22:05

New Istaroxime Phase 2b clinical results to be presented by Windtree and top cardiology expert Review of cardiogenic shock and other programs, including Windtree’s strategy and planned near-term milestones WARRINGTON, [...]

QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays

26/09/2024 - 22:05

Product line earns CE-marking under new EU IVDR framework – including QIAstat-Dx Analyzer, QIAstat-Dx Rise and panels for detection of gastrointestinal and respiratory infections // Certification confirms that QIAGEN’s [...]

NurExone Biologic Announces Private Placement of up to $2M and Closes First Tranche for $1.61M

26/09/2024 - 22:03

TORONTO and HAIFA, Israel, Sept. 26, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “ Company ” or “ NurExone ”), a biopharmaceutical company developing exosome-based [...]

Travere Therapeutics Announces Voluntary Pause of Enrollment in the Phase 3 HARMONY Study of Pegtibatinase Related to Commercial Manufacturing Scale-Up

26/09/2024 - 22:01

Company to host conference call today at 4:30 p.m. ET SAN DIEGO, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced a voluntary pause of enrollment in the Phase 3 HARMONY Study [...]

Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30

26/09/2024 - 22:01

CAMBRIDGE, Mass., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (“Seres” or the “Company”), a leading live biotherapeutics company, today announced that its stockholders voted to approve [...]

Clover Health Appoints Seasoned Healthcare Executive as Chief Operating Officer for Medicare Advantage Operations

26/09/2024 - 22:00

New Jersey Native Joseph Brand to Lead Operational Efficiency and Innovation in MA Operations, Enhancing Care for Physicians and Patients FRANKLIN, Tenn., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, [...]

Grant of Restricted Stock Units and Warrants to Employees in Genmab

26/09/2024 - 21:17

Company Announcement COPENHAGEN, Denmark; September 26, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that the Board decided to grant 23,954 restricted stock units and 13,915 warrants to employees of the Company and [...]

FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

26/09/2024 - 20:00

REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing oral covalent [...]

Corza Medical remporte le Prix d’excellence mondial 2024 du fabricant de solutions de suture de plaies le plus innovant

26/09/2024 - 19:12

WESTWOOD, Massachusetts, 26 sept. 2024 (GLOBE NEWSWIRE) -- Corza Medical (« Corza » ou la « Société »), une entreprise de technologie médicale de premier rang à l’échelle mondiale, proposant des services remarquables, [...]

Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome

26/09/2024 - 18:34

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clinical studies, MNV-201 demonstrated improved engraftment and bone marrow [...]

Culture Biosciences Appoints Chris Williams as Chief Executive Officer

26/09/2024 - 18:05

Former COO of Cytek Biosciences brings extensive bioprocessing experience to drive next phase of growth at Culture Biosciences South San Francisco, CA, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Culture Biosciences, a leader in [...]

OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update

26/09/2024 - 18:00

OSE Immunotherapeutics Announces Historic H1 2024 Results and Provides Corporate Update Financial and business highlights Total H1 2024 incomes of €82.5 million thanks to Company’s new partnerships. New strategic [...]

OSE Immunotherapeutics annonce des résultats semestriels 2024 remarquables et fait le point sur ses avancées

26/09/2024 - 18:00

OSE Immunotherapeutics annonce des résultats semestriels 2024 remarquables et fait le point sur ses avancées Éléments financiers et business développement Revenus du premier semestre 2024 de 82,5 millions d’euros grâce [...]

Vistin Pharma ASA: Mandatory notification of trade

26/09/2024 - 17:27

Saga Pure ASA has on 26 September 2024 purchased 50,000 shares in Vistin Pharma ASA at NOK 28.2 per share. After the transaction Saga Pure ASA has a holding of 700,000 shares, corresponding to 1.58% ownership.Saga Pure [...]

Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines

26/09/2024 - 16:30

First award under UNICEF emergency tender to secure availability of mpox vaccines for Africa COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the [...]

Bavarian Nordic Upgrades its Financial Guidance for 2024

26/09/2024 - 16:30

COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) upgrades its financial guidance for 2024. Based on today’s announced mpox vaccine order and additional orders secured, combined with improved [...]

Urteste Expands Development of Innovative Diagnostic Projects

26/09/2024 - 16:29

Urteste Expands Development of Innovative Diagnostic Projects Gdańsk, Poland – 26 SEPTEMBER 2024, 16:00 CET - Urteste S.A. (Warsaw Stock Exchange: URT), a biotechnology company specializing in the development of [...]

Acentra Health Earns Recertification to ISO 9001:2015 Standard for its Quality Management System

26/09/2024 - 16:23

Adherence to rigorous certification standards reinforces Acentra Health’s client-first commitment to delivering maximum value and impact with high quality solutions and services MCLEAN, Va., Sept. 26, 2024 (GLOBE [...]